Literature DB >> 29577869

Characterization of Liver- and Cancer-type-Organic Anion Transporting Polypeptide (OATP) 1B3 Messenger RNA Expression in Normal and Cancerous Human Tissues.

Khondoker Alam1, Taleah Farasyn1, Kai Ding2, Wei Yue1.   

Abstract

BACKGROUND: Membrane transport protein organic anion transporting polypeptide (OATP) 1B3 mediates the cellular uptake of many clinically important drugs including anti-cancer drugs (e.g., paclitaxel). In addition to the well-recognized hepatic expression and function of OATP1B3 [herein named liver-type (Lt) OATP1B3], OATP1B3 also expresses in cancers and has been postulated to play a role in cancer therapy, presumably by facilitating the influx of anti-cancer drugs. Recently, a cancer type (Ct)-OATP1B3 mRNA variant was identified in colon and lung cancer tissues, which encodes truncated Ct-OATP1B3 with negligible transport activity. Other than in colon and lung cancers, reports on mRNA expression of OATP1B3 in other cancers cannot distinguish between the Ltand Ct-OATP1B3.
OBJECTIVE: The current studies were designed to characterize the expression of Lt- and Ct-OATP1B3 mRNA in ovarian, prostate, bladder, breast, and lung tissues.
METHODS: Lt- and Ct-OATP1B3 isoform-specific PCR primers were utilized to determine the mRNA levels of Lt- and Ct-OATP1B3, respectively. An expression vector expressing green fluorescent protein (GFP)-tagged Lt-OATP1B3 was transiently transfected into the ovarian cancer cell line SKOV3. Confocal live-cell microscopy was utilized to determine the localization of GFP-Lt-OATP1B3 in SKOV3 cells.
RESULTS: For the first time, Lt-OATP1B3 mRNA was detected in ovarian, prostate, bladder and breast cancers. The localization of GFP-Lt-OATP1B3 on the plasma membrane of SKOV3 cells after transient transfection was readily detected by confocal microscopy.
CONCLUSION: Our findings are supportive of the potential role of Lt-OATP1B3 in cancer cells. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Organic anion transporting polypeptide (OATP) 1B3; bladder; breast; cancer; lung; mRNA; ovary; prostate; transport protein.

Mesh:

Substances:

Year:  2018        PMID: 29577869      PMCID: PMC6133766          DOI: 10.2174/1872312812666180326110146

Source DB:  PubMed          Journal:  Drug Metab Lett        ISSN: 1872-3128


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Multispecific amphipathic substrate transport by an organic anion transporter of human liver.

Authors:  X Bossuyt; M Müller; P J Meier
Journal:  J Hepatol       Date:  1996-11       Impact factor: 25.083

Review 3.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

4.  The N-terminal region of organic anion transporting polypeptide 1B3 (OATP1B3) plays an essential role in regulating its plasma membrane trafficking.

Authors:  Se-Eun Chun; Nilay Thakkar; Yunseok Oh; Ji Eun Park; Songhee Han; Gongmi Ryoo; Hyunggu Hahn; Sang Hyun Maeng; Young-Ran Lim; Byung Woo Han; Wooin Lee
Journal:  Biochem Pharmacol       Date:  2017-02-23       Impact factor: 5.858

5.  LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.

Authors:  T Abe; M Unno; T Onogawa; T Tokui; T N Kondo; R Nakagomi; H Adachi; K Fujiwara; M Okabe; T Suzuki; K Nunoki; E Sato; M Kakyo; T Nishio; J Sugita; N Asano; M Tanemoto; M Seki; F Date; K Ono; Y Kondo; K Shiiba; M Suzuki; H Ohtani; T Shimosegawa; K Iinuma; H Nagura; S Ito; S Matsuno
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

Review 6.  SLC transporters as therapeutic targets: emerging opportunities.

Authors:  Lawrence Lin; Sook Wah Yee; Richard B Kim; Kathleen M Giacomini
Journal:  Nat Rev Drug Discov       Date:  2015-06-26       Impact factor: 84.694

7.  Identification of a new organic anion transporting polypeptide 1B3 mRNA isoform primarily expressed in human cancerous tissues and cells.

Authors:  Miki Nagai; Tomomi Furihata; Sayaka Matsumoto; Seiya Ishii; Shinichiro Motohashi; Ichiro Yoshino; Miyuki Ugajin; Atsushi Miyajima; Shogo Matsumoto; Kan Chiba
Journal:  Biochem Biophys Res Commun       Date:  2012-01-30       Impact factor: 3.575

8.  Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux.

Authors:  K M Tainton; M J Smyth; J T Jackson; J E Tanner; L Cerruti; S M Jane; P K Darcy; R W Johnstone
Journal:  Cell Death Differ       Date:  2004-09       Impact factor: 15.828

Review 9.  The SLCO (former SLC21) superfamily of transporters.

Authors:  Bruno Hagenbuch; Bruno Stieger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

10.  Novel mechanism of impaired function of organic anion-transporting polypeptide 1B3 in human hepatocytes: post-translational regulation of OATP1B3 by protein kinase C activation.

Authors:  John Powell; Taleah Farasyn; Kathleen Köck; Xiaojie Meng; Sonia Pahwa; Kim L R Brouwer; Wei Yue
Journal:  Drug Metab Dispos       Date:  2014-09-08       Impact factor: 3.922

View more
  3 in total

1.  Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer.

Authors:  Martin Svoboda; Felicitas Mungenast; Andreas Gleiss; Ignace Vergote; Adriaan Vanderstichele; Jalid Sehouli; Elena Braicu; Sven Mahner; Walter Jäger; Diana Mechtcheriakova; Dan Cacsire-Tong; Robert Zeillinger; Theresia Thalhammer; Dietmar Pils
Journal:  Front Pharmacol       Date:  2018-08-07       Impact factor: 5.810

2.  Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer.

Authors:  Katharina Woess; Yuchen Sun; Hanae Morio; Anna Stierschneider; Anna Kaufmann; Stefan Hainzl; Lisa Trattner; Thomas Kocher; Birgit Tockner; Victoria Leb-Reichl; Markus Steiner; Gabriele Brachtl; Andrew P South; Johann W Bauer; Julia Reichelt; Tomomi Furihata; Verena Wally; Ulrich Koller; Josefina Piñón Hofbauer; Christina Guttmann-Gruber
Journal:  Int J Mol Sci       Date:  2022-01-05       Impact factor: 5.923

3.  Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.

Authors:  Shihan Chen; Kun Li; Jiayun Jiang; Xiaofei Wang; Yuelong Chai; Chang Zhang; Qingsong Deng; Ling Shuai; Kai Feng; Kuansheng Ma; Leida Zhang
Journal:  World J Surg Oncol       Date:  2020-06-13       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.